South Wales, Nov. 20 -- UK Intellectual Property Office has received a patent application (GB2610984.3) with the title ‘T CELL ACTIVATION-INDUCED SILENCING.’

Here are the other details related to the patent application:

Status: Filed

Filing Date: 2026-05-11

Owner(s): Laverock Therapeutics Ltd.

Disclaimer: Curated by HT Syndication.